Company Data

ZIOPHARM Oncology Inc

Ticker
ZIOP
Market Cap
$623.9M
Price Target
Refer to Report
Volume
238
52wk Range
$38.89 - $58.18
Advanced Market Data

Overview

ZIOPHARM Oncology Inc is a biotechnology company that acquires, develops, and commercializes cancer therapies. The company’s preclinical and clinical pipeline focuses on treating hematological and solid tumor malignancies using cellular therapeutics. Ziopharm engages in gene therapy systems with its partner Intrexon and collaborators at the University of Texas. To fund the development of its product candidates, the company engages in contractual arrangements with licensing partners both in the United States and abroad.

Inbox Intel from Channelchek.

Informed investors make more money. And it’s all about timing. Get it when it happens.

By clicking submit you are agreeing to the Terms of Use and Privacy Policy
© 2018-2022 Noble Financial Group, Inc. All Rights Reserved. Channelchek is provided at no cost to be used for information purposes only and not as investment advisement.